Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
But I think the Chinese scientist that experimented on babies did it few years before that even. looks like same year, 2018, and thought emporium published first by 8 months
Thought emporium?
Yep thought emporium.
But I think the Chinese scientist that experimented on babies did it few years before that even.looks like same year, 2018, and thought emporium published first by 8 monthshttps://pmc.ncbi.nlm.nih.gov/articles/PMC6724388/
That paper is a wild read